Otonomy (OTIC) Q4 2021 Earnings Call Transcript
OTIC earnings call for the period ending December 31, 2021.
Stay updated with breaking news from Otonomy Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OTIC earnings call for the period ending December 31, 2021.
Cisplatin-Induced Hearing Loss (CIHL) – Market Insight, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Cisplatin-Induced Hearing Loss (CIHL) – Market Insight, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
03.01.2022 - SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) - Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the H.C. Wainwright BioConnect ...
Robinson’s expertise in development and commercialization adds to the clinical and commercial experience of newly appointed management team...